The use of living sources and materials in the manufacturing of biological products means the development process from concept to therapeutic is more complex than chemically synthesized drugs. Consequently, a whole host of tools can be adopted at different stages of the biopharmaceutical development pipeline for varying types of analyses.
Download this infographic to learn about:
The heterogeneity of biological products
The toolbox of analytical techniques that can be used at different stages of the biopharmaceutical R&D timeline
